The Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
The high prevalence of methicillin resistance among Staphylococcus aureus bacteremias leads to common use of vancomycin as empirical therapy. However, investigators have reported poor outcomes with vancomycin treatment for methicillin-susceptible Staphylococcus aureus bacteremia. We review the evidence supporting empirical combination of both vancomycin and a β-lactam agent for Staphylococcus aureus bacteremia. Vancomycin therapy for methicillin-susceptible Staphylococcus aureus bacteremia is associated with 2-3 times the risk of morbidity and mortality compared to an antistaphylococcal penicillin (oxacillin and nafcillin) or first-generation cephalosporin (cefazolin). De-escalation of empirical vancomycin to definitive β-lactam therapy still appears inferior to initial β-lactam therapy. Although there is no clinical trial supporting combination therapy, a scientific rationale for benefit exists and should be weighed against the risks (adverse events, antibiotic resistance, and cost) of additional pharmacotherapy. The empirical combination of vancomycin and a β-lactam (either nafcillin, oxacillin, or cefazolin) for staphylococcal bacteremia may improve infection-related clinical outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The meta-analysis included small, retrospective studies, however, which limits support for initial combination therapy by some experts.”
In the citing paper
“An analysis of the literature, however, compared the use of empirical combination of vancomycin and antistaphylococcal β-lactam therapy with vancomycin alone and demonstrated the superiority of β-lactam-containing regimens over vancomycin monotherapy for bacteremic MSSA infections, including IE. 154”
Citations
Cites
Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P., & Edmond, M. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421946 · Cited by 4,496 · cited 4×
“MRSA in the United States is endemic in the community and hospital setting.”
InfluentialLiu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq146 · Cited by 4,191
Hidron, A. I., Edwards, J. R., Patel, J., Horan, T. C., Sievert, D. M., Pollock, D. A., Fridkin, S. K., & National Healthcare Safety Network Team and Participating National Healthcare Safety Network Facilities (2008) · Infection Control & Hospital Epidemiology · doi:10.1086/591861 · Cited by 3,724
Sievert, D. M., Ricks, P., Edwards, J. R., Schneider, A., Patel, J., Srinivasan, A., Kallen, A., Limbago, B., Fridkin, S., & National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities (2013) · Infection Control & Hospital Epidemiology · doi:10.1086/668770 · Cited by 1,582
Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus
Fowler, V. G., Boucher, H. W., Corey, G. R., Abrutyn, E., Karchmer, A. W., Rupp, M. E., Levine, D. P., Chambers, H. F., Tally, F. P., Vigliani, G. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053783 · Cited by 1,459
Lodise, T. P., McKinnon, P. S., Swiderski, L., & Rybak, M. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375057 · Cited by 604
Chang, F.-Y., Peacock, J. E., Musher, D. M., Triplett, P., MacDonald, B. B., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091184.93122.09 · Cited by 530
Frazee, B. W., Lynn, J., Charlebois, E. D., Lambert, L., Lowery, D., & Perdreau-Remington, F. (2005) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2004.10.011 · Cited by 494 · cited 1×
“In one study, approximately 50% of emergency department visits for skin and soft tissue infections were positive for MRSA [8].”
Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1
Berthoud, T. K., Hamill, M., Lillie, P. J., Hwenda, L., Collins, K. A., Ewer, K. J., Milicic, A., Poyntz, H. C., Lambe, T., Fletcher, H. A., et al. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq015 · Cited by 384
Chang, F.-Y., MacDonald, B. B., Peacock, J. E., Musher, D. M., Triplett, P., Mylotte, J. M., O’Donnell, A., Wagener, M. M., & Yu, V. L. (2003) · Medicine · doi:10.1097/01.md.0000091185.93122.40 · Cited by 349
Research works printed but not linked: 4
- 2011, Clinical Infectious Diseases, 531, S4
- Parta, 2010, Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America, 31, 1043, 10.1086/656248 · doi:10.1086/656248 · Paper page
- Rudolph, 1973, JAMA, 223, 499, 10.1001/jama.1973.03220050011003 · doi:10.1001/jama.1973.03220050011003
- 1971, Postgraduate Medical Journal, 47, 64
Cited by
Baddour, L. M., Wilson, W. R., Bayer, A. S., Fowler, V. G., Tleyjeh, I. M., Rybak, M. J., Barsic, B., Lockhart, P. B., Gewitz, M. H., Levison, M. E., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000296 · Cited by 3,232
Clinical Management of Staphylococcus aureus Bacteremia: A Review
Holland, T. L., Arnold, C., & Fowler, V. G. (2014) · JAMA · doi:10.1001/jama.2014.9743 · Cited by 449
Holland, T. L., Baddour, L. M., Bayer, A. S., Hoen, B., Miro, J. M., & Fowler, V. G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.59 · Cited by 406
Woods, C. R., Bradley, J. S., Chatterjee, A., Copley, L. A., Robinson, J., Kronman, M. P., Arrieta, A., Fowler, S. L., Harrison, C., Carrillo-Marquez, M. A., et al. (2021) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab027 · Cited by 308
Leong, H. N., Kurup, A., Tan, M. Y., Kwa, A. L., Liau, K. H., & Wilcox, M. H. (2018) · Infection and Drug Resistance · doi:10.2147/idr.s172366 · Cited by 120
Dhand, A., & Sakoulas, G. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.09.005 · Cited by 80
Contemporary Management of Staphylococcus aureus Bacteremia—Controversies in Clinical Practice
Minter, D. J., Appa, A. A., Chambers, H. F. “., & Doernberg, S. B. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad500 · Cited by 86
Role of Operative or Interventional Radiology-Guided Cultures for Osteomyelitis
McNeil, J. C., Forbes, A., Vallejo, J. G., Flores, A. R., Hultén, K. G., Mason, E. O., & Kaplan, S. L. (2016) · PEDIATRICS · doi:10.1542/peds.2015-4616 · Cited by 71
Ortwine, J. K., Werth, B. J., Sakoulas, G., & Rybak, M. J. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2013.10.002 · Cited by 70
The Golden Grapes of Wrath – Staphylococcus aureus Bacteremia: A Clinical Review
Lam, J. C., & Stokes, W. (2022) · The American Journal of Medicine · doi:10.1016/j.amjmed.2022.09.017 · Cited by 77
Gudiol, F., Aguado, J. M., Almirante, B., Bouza, E., Cercenado, E., Domínguez, M. Á., Gasch, O., Lora-Tamayo, J., Miró, J. M., Palomar, M., et al. (2015) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2015.03.015 · Cited by 78
Felsenstein, S., Bender, J. M., Sposto, R., Gentry, M., Takemoto, C., & Bard, J. D. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2015-0119-oa · Cited by 56
McNeil, J. C., Kok, E. Y., Forbes, A., Lamberth, L. B., Hultén, K. G., Vallejo, J. G., Mason, E. O., & Kaplan, S. L. (2015) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000000991 · Cited by 53
The Mechanisms of Resistance to β-Lactam Antibiotics
King, D. T., Sobhanifar, S., & Strynadka, N. C. J. (2017) · Springer eBooks · doi:10.1007/978-1-4939-0694-9_10 · Cited by 75
Wong, D., Wong, T., Romney, M. G., & Leung, V. C. M. (2016) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-016-0143-3 · Cited by 51
Goto, M., Jones, M. P., Schweizer, M. L., Livorsi, D. J., Perencevich, E. N., Richardson, K. K., Beck, B. F., ALEXANDER, B. K., & Ohl, M. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2019.21048 · Cited by 50
Bacteremia, Sepsis, and Infective Endocarditis Associated with Staphylococcus aureus
Bergin, S. P., Holland, T. L., Fowler, V. G., & Tong, S. Y. C. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_5001 · Cited by 51
Off-label use of ceftaroline fosamil: A systematic review
Pani, A., Colombo, F., Agnelli, F., Frantellizzi, V., Baratta, F., Pastori, D., & Scaglione, F. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.06.025 · Cited by 53
Treatment of gram - positive infections in critically ill patients
Guillamet, C. V., & Kollef, M. H. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-92 · Cited by 55
Watson, A., Oh, J. T., Sauve, K., Bradford, P. A., Cassino, C., & Schuch, R. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01078-19 · Cited by 46
Pharmacotherapeutic options for treating Staphylococcus aureus bacteremia
Gudiol, C., Cuervo, G., Shaw, E., Pujol, M., & Carratalà, J. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1403585 · Cited by 63
Zhou, T., Li, Z., Kang, O., Mun, S., Seo, Y., Kong, R., Shin, D.-W., Liu, X., & Kwon, D.-Y. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3099 · Cited by 37
New antibiotics against gram-positives: present and future indications
Morata, L., Mensa, J., & Soriano, À. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.07.004 · Cited by 31
Alosaimy, S., Sabagha, N., Lagnf, A. M., Zasowski, E. J., Morrisette, T., Jorgensen, S. C. J., Trinh, T. D., Mynatt, R. P., & Rybak, M. J. (2020) · Infectious Diseases and Therapy · doi:10.1007/s40121-020-00292-8 · Cited by 35
Zheng, X., Berti, A. D., McCrone, S., Roch, M., Rosato, A. E., Rose, W. E., & Chen, B. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02100-17 · Cited by 34
Di, W., Jin, Z., Lei, W., Liu, Q., Yang, W., Zhang, S., Lu, C., Xu, X., Yang, Y., & Zhao, H. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00415-8 · Cited by 33
Grillo, S., Puig‐Asensio, M., Schweizer, M. L., Cuervo, G., Oriol, I., Pujol, M., & Carratalà, J. (2022) · Microorganisms · doi:10.3390/microorganisms10050848 · Cited by 22
Delport, J. A., Mohorovic, I., Burn, S., McCormick, J. K., Schaus, D., Lannigan, R., & John, M. (2016) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000285 · Cited by 23
Wong, D., Wong, T., Romney, M. G., & Leung, V. C. M. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1564-5 · Cited by 19
Vardakas, K. Z., Apiranthiti, K. N., & Falagas, M. E. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.09.002 · Cited by 17
Berti, A. D., Hutson, P. R., Schulz, L. T., Webb, A. P., & Rose, W. E. (2015) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp140369 · Cited by 16
Li, Z.-P., Li, J., Qu, D., Hou, Z., Yang, X., Zhang, Z., Wang, Y., Luo, X., & Li, M. (2014) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12343 · Cited by 16
Castañeda, X., García-de-la-Mària, C., Gasch, O., Pericàs, J. M., Soy, D., Cañas-Pacheco, M. A., Falces, C., García‐González, J., Meneses, M. H., Vidal, B., et al. (2021) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkab069 · Cited by 17
Choi, J.-G., Choi, J., Mun, S., Kang, O., Bharaj, P., Shin, D.-W., Chong, M.-S., & Kwon, D. (2015) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2015.06.010 · Cited by 14
Tang, H.-J., Lai, C., Chen, C.-C., Zhang, C.-C., Weng, T., Yu, W., Chen, H.-J., Chiu, Y.-H., Ko, W., & Chuang, Y.-C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00884 · Cited by 14
Ersoy, S. C., Hanson, B., Proctor, R. A., Arias, C. A., Tran, T. T., Chambers, H. F. “., & Bayer, A. S. (2021) · Genes · doi:10.3390/genes12111650 · Cited by 14
Kong, P., Chiang, C.-H., Lin, T.-C., Kuo, S., Li, C., Hsiung, C. A., Shiue, Y., Chiou, H.-Y., Wu, L.-C., & Tsou, H. (2022) · Pathogens · doi:10.3390/pathogens11050586 · Cited by 15
Ceftobiprole medocaril (BAL-5788) for the treatment of complicated skin infections
Deitchman, A. N., de Jong, D., Barbour, A., & Derendorf, H. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1244481 · Cited by 12
The Mechanisms of Resistance to β-Lactam Antibiotics
King, D. T., Sobhanifar, S., & Strynadka, N. C. J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0667-3_10-1 · Cited by 17
Wang, Y., Fan, H., Huang, X.-M., & Jiao, Y. (2023) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-023-03932-x · Cited by 10
Lê, J., Dam, Q., Schweizer, M. L., Thienphrapa, W., Nizet, V., & Sakoulas, G. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2682-0 · Cited by 10
Park, G., Ko, J., Cho, S. Y., Ha, Y. E., Lee, N. Y., Kang, C., Chung, D. R., Song, J., & Peck, K. R. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2893-4 · Cited by 10
Yavuz, S. Ş., Akar, A., Aydoğdu, S., Berzeg-Deniz, D., Demir, H., Hazırolan, T., Özatık, M. A., Özer, N., Sarğın, M., Topçuoğlu, N., et al. (2020) · Turkish Journal of Thoracic and Cardiovascular Surgery · doi:10.5606/tgkdc.dergisi.2020.01954 · Cited by 13
Bakthavatchalam, Y. D., Ralph, R., Veeraraghavan, B., Babu, P., & Munusamy, E. (2018) · Infectious Diseases and Therapy · doi:10.1007/s40121-018-0224-z · Cited by 9
Escalation of antimicrobial resistance among MRSA part 2: focus on infections and treatment
Lynch, J. P., & Zhanel, G. G. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2023.2154654 · Cited by 10
Turner, R. B., Lalikian, K., Fry, M. M., Schwartz, J., Chan, D., & Won, R. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.07.003 · Cited by 9
Melatonin Exerts Positive Effects on Sepsis Through Various Beneficial Mechanisms
Xu, J., Liang, C., Yao, S., & Wang, F. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s509735 · Cited by 8
Petraitis, V., Petraitienė, R., Kavaliauskas, P., Naing, E., Garcia, A. J., Sutherland, C. A., Kau, A. Y., Goldner, N. K., Bulow, C., Nicolau, D. P., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01168-21 · Cited by 7
Staphylococcus aureusBacteremia: Targeting the Source
Rongpharpi, S. R., Duggal, S., Kalita, H., & Duggal, A. K. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.09.2811 · Cited by 7
The Mechanisms of Resistance to b-Lactam Antibiotics
King, D. T., Sobhanifar, S., & Strynadka, N. C. J. (2014) · Cited by 7
Ceftobripole: Experience in staphylococcal bacteremia.
Soriano, À., & Morata, L. (2019) · PubMed Central · Cited by 9
Yamada, K., Ueda, T., Nakajima, K., Ichiki, K., Tsuchida, T., Otani, N., Takahashi, Y., Ikeuchi, H., Uchino, M., Koshiba, M., et al. (2019) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2019.12.006 · Cited by 6
Ishikawa, K., & Furukawa, K. (2021) · Cureus · doi:10.7759/cureus.16607 · Cited by 9
Non availability of Cloxacillin, A Deterrent for Rational Antimicrobial Practice.
Srinivasaraghavan, R., & Dhandapany, G. (2016) · PubMed · Cited by 5
Soriano, À. (2017) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-017-5355-0 · Cited by 5
Redeploying β-Lactams AgainstStaphylococcus aureus:Repurposing With a Purpose
Bayer, A. S., & Xiong, Y. Q. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw464 · Cited by 5
Adjunctive β-lactams for Staphylococcus aureus bacteremia: a narrative review
Chastain, D. B., White, B. P., Henao‐Martínez, A. F., Tu, P. J., Bland, C. M., Foster, R. A., & Cluck, D. B. (2025) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361251343969 · Cited by 6
Rasheed, N., Galant, N. J., & Csizmadia, I. G. (2018) · Anti-Infective Agents · doi:10.2174/2211352516666181112125458 · Cited by 4
Methicillin-resistant Staphylococcus aureus Infection and its Health Perspective: A Review
Thomas, A., Palathoti, N., & Azam, M. A. (2024) · Current Pharmaceutical Biotechnology · doi:10.2174/0113892010310231240529075731 · Cited by 6
Mehta, Y. B., Mishra, K. C., Paliwal, Y., Rangappa, P., Sinha, S., & Bhapkar, S. (2022) · Critical Care Research and Practice · doi:10.1155/2022/2668199 · Cited by 4
da Silva, S. C. S. B., Fachi, M. M., Ricieri, M. C., & Motta, F. D. A. (2024) · Infection Prevention in Practice · doi:10.1016/j.infpip.2024.100419 · Cited by 5
Lewis, P. O., Sevinsky, R., Patel, P. D., Krolikowski, M. A., & Cluck, D. B. (2018) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936118797404 · Cited by 3
[Current status of antibiotic therapy for Staphylococcus aureus sepsis in children].
Li, Y., Li, Q., Zhang, G., Tian, X., Chen, D., & Luo, Z. (2019) · PubMed · doi:10.7499/j.issn.1008-8830.2019.04.016 · Cited by 3
Yu, G., Lou, Y., He, L., Wang, Z., & Ren, Y. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05164-y · Cited by 4
Ramakrishna, J. M., Khosla, A. A., Kröner, P. T., Brahmbhatt, B. S., Stancampiano, F. F., & Libertin, C. R. (2022) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2022.101104 · Cited by 2
Tsai, C.-Y., Lee, C., & Chen, I. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06111-w · Cited by 2
The Impact of Pharmacy-Based Immunization on Vaccination Rates and Prevalence of Influenza Virus
McConeghy, K. W. (2015) · Figshare · Cited by 2
Self-citationCoronado-Álvarez, N. M., & Parra-Ruiz, J. (2015) · Journal of Infection · doi:10.1016/j.jinf.2015.12.002 · Cited by 2
Ishikawa, K., Furukawa, K., & Hoshino, E. (2021) · Research Square · doi:10.21203/rs.3.rs-127180/v1 · Cited by 2
A Potential Novel Antimicrobial Peptide for Staphylococcus Infection in Skin
İmrak, G., Oztabak, D., Boyuk, E., Kilic, B., & Karaaslan, Ç. (2025) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-025-10760-9 · Cited by 1
Alsuwaylihi, A., Alshehri, A. M., & Yami, M. S. A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15031024 · Cited by 1
Compatibility of Vancomycin and Oxacillin during Simulated Y-Site Delivery
Teibel, H. M., Knoderer, C. A., & Nichols, K. R. (2015) · Hospital Pharmacy · doi:10.1310/hpj5008-710 · Cited by 1
Treating endocarditis: A protocol of an antimicrobal treatment from a middle-income country
Barbosa, G. F., Zappa, B. C., Garrido, R. Q., & Lamas, C. D. C. (2018) · Heart Vessels and Transplantation · doi:10.24969/hvt.2018.65 · Cited by 1
Sahraei, Z., Shokouhi, S., Meskinimood, S., & Barati, S. (2022) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2022.06.001 · Cited by 1
Clinical characteristics and prognosis of Staphylococcus aureus bacteremia
Fenoll, R. G., Espinosa-Pérez, M., Bayo, S. M., Millán, V. F., Jiménez, M. C. M., Álvarez, R. M. M., Ruíz, M. P. P., Usón, M. C. V., & Paesa, C. R. (2022) · Revista Española de Quimioterapia · doi:10.37201/req/035.2022 · Cited by 3
Ten old antibiotics that will never disappear
Bassetti, M., Falagas, M. E., & Kollef, M. H. (2015) · Intensive Care Medicine · doi:10.1007/s00134-015-3705-5 · Cited by 1
Long, V. (2014) · Loyola eCommons (Loyola University of Chicago)
Pea, F., Petrosillo, N., & Garau, J. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1056159
Common Use of the Empirical Combination of Vancomycin and a -Lactam for Staphylococcal Bacteremia
Cleveland, K. O., Mazumder, S. A., & Gelfand, M. S. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu029
Advanced Methods for Screening and Identification of Methicillin-Resistant Staphylococcus aureus
Widen, R. E., & Tang, Y. (2018) · Springer eBooks · doi:10.1007/978-3-319-95111-9_7
Lee, C., Tsai, C.-Y., & Chen, I. (2020) · Research Square · doi:10.21203/rs.3.rs-59403/v1
Tsai, C.-Y., Lee, C.-H., & Chen, I. (2020) · Research Square · doi:10.21203/rs.3.rs-59403/v2
Xu, J., Hua, C., Ye, W., Shi, S., & Shu, Q. (2020) · doi:10.21203/rs.3.rs-29089/v1
Inflammatory bowel disease complicated with rare pathogen infection
Fang, J., & Li, G. (2023) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v31.i1.8
Brain Abscess After Cerebral Hemorrhage in a Patient with Staphylococcus aureus Bacteremia
Kudo, S., Kuno, M., MOCHIZUKI, T., SUZUKI, H., Michiko, S. A. T. O., Saito, K., KURIHARA, T., & Yokobori, S. (2023) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.e22014
Mohammed, N. A., Zaki, B. S., & Ahmed, F. (2023) · Journal of Current Medical Research and Practice · doi:10.4103/jcmrp.jcmrp_56_23
Tsai, C.-Y., Lee, C.-H., & Chen, I.-L. (2021) · Figshare · doi:10.6084/m9.figshare.14583532
Di, W., 金振晓, Lei, W., Liu, Q., Yang, W., Zhang, S., Lu, C., Xu, X., Yang, Y., & Zhao, H. (2024) · Figshare · doi:10.6084/m9.figshare.26585181
Association of antibiotic type and timing with sepsis mortality using target trial emulation
Li, J., Zhao, M., & He, Q. (2026) · Scientific Reports · doi:10.1038/s41598-026-40860-5 · Cited by 3
Zhao, C., Ren, R., Wu, W., Liu, J., Chen, C., Yin, N., & Li, L. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1805801
Metadata
- Authors
- McConeghy, K. W., Bleasdale, S. C., & Rodvold, K. A.
- Affiliations
- University of Illinois Chicago (US)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-08-28
- Volume
- 57
- Issue
- 12
- Pages
- 1760-1765
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2157481885
- Semantic Scholar
- 978015d30fdc02a4a6b93c21edf1e68c6ece1978
- Cited by
- 90
- References
- 47
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 6 · 2022: 8 · 2021: 8 · 2020: 6 · 2019: 5 · 2018: 6 · 2017: 8 · 2016: 10 · 2015: 12 · 2014: 10 · 2013: 1
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pfizer
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
- Keywords
- vancomycin, beta-lactam antibiotics, Staphylococcus aureus bacteremia, methicillin-susceptible Staphylococcus aureus, oxacillin, nafcillin, cefazolin, de-escalation, antibiotic adverse events, antibiotic costs
- MeSH terms
- Anti-Bacterial Agents, Drug Therapy, Combination, Humans, Staphylococcal Infections, Vancomycin, Cohort Studies, Bacteremia, beta-Lactams, Methicillin-Resistant Staphylococcus aureus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.